8-K: RCM Technologies Reports Mixed Q3 2025 Results

RCM Technologies announced increased revenue for Q3 2025 and year-to-date, alongside mixed profit metrics and strong forward-looking statements for Q4 and 2026.

Summary

• Revenue for the thirteen weeks ended September 27, 2025, increased by 16.4% to $70.3 million, up from $60.4 million in the comparable prior quarter.
• Gross profit for the current quarter rose by 8.8% to $19.4 million, compared to $17.8 million in the prior quarter.
• GAAP net income for the current quarter was $2.3 million, or $0.30 per diluted share, a decrease from $2.7 million, or $0.35 per diluted share, in the comparable prior quarter.
• Adjusted EBITDA (non-GAAP) for the current quarter was $5.5 million, a slight decrease from $5.6 million in the comparable prior quarter.
• Adjusted net income per diluted share (non-GAAP) remained flat at $0.42 for both the current and comparable prior quarters.
• Year-to-date revenue for the thirty-nine weeks ended September 27, 2025, increased by 15.6% to $232.9 million, up from $201.5 million in the comparable prior-year period.
• Year-to-date gross profit increased by 9.4% to $63.7 million, compared to $58.2 million in the prior-year period.
• Year-to-date GAAP net income was $10.2 million, or $1.34 per diluted share, a decrease from $10.5 million, or $1.31 per diluted share, in the comparable prior-year period (diluted EPS increased due to lower share count).
• Year-to-date adjusted EBITDA (non-GAAP) increased by 9.2% to $21.4 million, up from $19.6 million in the prior-year period.
• Year-to-date adjusted net income per diluted share (non-GAAP) increased by 12.3% to $1.73, compared to $1.54 in the prior-year period.
• Cash and cash equivalents decreased from $4.729 million at December 28, 2024, to $1.309 million at September 27, 2025.
• Net cash provided by operating activities for the thirty-nine weeks ended September 27, 2025, was $7.520 million, a slight decrease from $7.807 million in the prior-year period.

Sentiment

Score: 6

Explanation: The company shows strong revenue growth and positive adjusted metrics for the year-to-date, coupled with an optimistic outlook for future quarters. However, the decline in GAAP net income and diluted EPS for the quarter and year-to-date net income presents a mixed financial picture, tempering overall sentiment.

Positives

• Strong revenue growth of 16.4% for the quarter and 15.6% year-to-date.
• Year-to-date adjusted EBITDA increased by 9.2% to $21.4 million.
• Year-to-date adjusted diluted net earnings per share increased by 12.3% to $1.73.
• Executive Chairman noted entering the fourth quarter from a position of strength with record 2026 Engineering backlog as of the end of October and continued momentum in Healthcare.
• CFO expects the fourth quarter to yield the highest quarterly gross profit and adjusted EBITDA in fiscal 2025.

Negatives

• GAAP net income decreased by 14.8% for the current quarter to $2.3 million.
• GAAP diluted net earnings per share decreased by 14.3% for the current quarter to $0.30.
• GAAP net income for the thirty-nine weeks decreased by 2.9% to $10.2 million.
• Adjusted EBITDA (non-GAAP) for the current quarter slightly decreased by 1.8% to $5.5 million.
• Overall gross profit margin declined to 27.6% for the quarter (from 29.6%) and 27.3% year-to-date (from 28.9%).
• Cash and cash equivalents decreased by $3.420 million year-to-date.
• Gross profit margin in the Specialty Health Care segment decreased to 30.0% for the quarter (from 31.2%) and 28.8% year-to-date (from 29.5%).
• Gross profit margin in the Engineering segment decreased to 22.0% for the quarter (from 24.4%) and 21.7% year-to-date (from 24.7%).

Risks

• Actual results, performance, or achievements could differ materially from forward-looking statements due to various risks, uncertainties, and other factors.
• Risks include those related to demand for services, future revenues and other financial results, cash flows, pipeline, potential project wins, and expectations for investment and growth in the business.
• Investors are directed to consider risks, uncertainties, and other factors described in documents filed with the SEC, including the most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.

Future Outlook

Management anticipates entering the fourth quarter from a position of strength, driven by record 2026 Engineering backlog as of the end of October and continued momentum in Healthcare. The company expects the fourth quarter of fiscal 2025 to yield its highest quarterly gross profit and adjusted EBITDA, expressing excitement about momentum heading into 2026.

Management Comments

• "As we exit our seasonal third quarter, we are entering the fourth quarter from a position of strength, demonstrating record 2026 Engineering backlog as of the end of October and continued momentum in Healthcare." Bradley Vizi, Executive Chairman.
• "We expect our fourth quarter will yield our highest quarterly gross profit and adjusted EBITDA in fiscal 2025, and we are excited about our momentum heading into 2026." Kevin Miller, Chief Financial Officer.

Industry Context

RCM Technologies operates across diverse sectors including Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences, and Data & Solutions. The reported strong revenue growth of over 15% for both the quarter and year-to-date suggests robust demand for its specialized services, particularly highlighted by the record Engineering backlog and continued momentum in Healthcare. This performance indicates the company is effectively capitalizing on modernization and critical infrastructure needs within its target industries.

Comparison to Industry Standards

• No specific comparable companies, projects, or industry benchmarks are provided within the filing to assess results against global standards.
• The company's reported revenue growth of 16.4% for the quarter and 15.6% year-to-date in its diverse service segments (Healthcare, Engineering, Life Sciences, Data & Solutions) indicates strong top-line performance.
• This growth rate could be considered favorable depending on the specific industry sub-sectors and overall market growth rates for professional services, though direct comparisons are not available in this document.

Stakeholder Impact

• Shareholders: Mixed financial results with strong revenue growth and positive adjusted metrics, but declining GAAP net income. The positive outlook for Q4 and 2026 could instill confidence.
• Employees: Continued revenue growth and positive outlook suggest stability and potential for ongoing employment and opportunities.
• Customers: The company continues to provide advanced engineering, specialty health care, and information technology services, with strong backlog indicating ongoing project delivery.

Next Steps

• Host a conference call on Thursday, November 6, 2025, at 11:30 a.m. Eastern Time to discuss the results.
• Focus on entering the fourth quarter from a position of strength, leveraging record 2026 Engineering backlog and continued momentum in Healthcare.
• Work towards achieving the highest quarterly gross profit and adjusted EBITDA in fiscal 2025 during the fourth quarter.
• Continue building momentum heading into fiscal year 2026.

Key Dates

Recommendation

RCM Technologies demonstrated robust revenue growth for both the quarter and year-to-date, alongside positive trends in adjusted EBITDA and adjusted diluted EPS for the year. Management's forward-looking statements are highly optimistic, citing record Engineering backlog and strong momentum into 2026. However, the decline in GAAP net income and diluted EPS for the current quarter, and a year-to-date decrease in GAAP net income, indicates some pressure on core profitability despite top-line expansion. This mixed performance, with strong operational indicators but weaker GAAP bottom-line figures, suggests a 'hold' recommendation. Investors should monitor future filings for sustained improvement in GAAP profitability to complement the impressive revenue growth and positive outlook.

Keywords

RCM Technologies, RCMT, Q3 2025 Earnings, Financial Results, Engineering Services, Healthcare Services, Information Technology Services, Adjusted EBITDA, Revenue Growth, Net Income, EPS, Backlog